USPTO serial 79437594
STRIMVELIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOLFE, YOUNG J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with STRIMVELIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
Michael J. Leonard Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for gene therapy for the treatment of severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID); pharmaceutical preparations for the treatment of adenosine deaminase severe combined immunodeficiency (ADA-SCID) using autologous 34+ cells transduced to express adenosine deaminase (ADA); pharmaceutical preparations for treating ADA-SCID | ACTIVE | — |
| 042 | Biological research, clinical research in the field of gene therapy and medical research; medical research laboratory services; research and development of vaccines and medicines; scientific research services in the preparation of biological samples f o r testing and analysis in research laboratories; genetic scientific research; scientific research and development; pharmaceutical drug development services; providing information on clinical studies via an interactive website; medical and scientific research, namely, conducting clinical trials for others; DNA screening for scientific research purposes; design and development of computer hardware and software; research and development of new products for others; conducting technical scientific feasibility project studies; rental of computer software for collecting, analysing and organizing data in the field of medical research and treatment of genetic diseases; computer programming; conversion of computer programs and data, other than physical conversion; recovery of computer data; quality control for others; material testing; engineering, namely, surveying; conversion of data or documents from physical to electronic media; bacteriological research; hosting of communication computer platforms on the internet; programming of software for Internet platforms; pharmaceutical products development; scientific research services; scientific laboratory services; structural and functional analysis of genomes; development of pharmaceutical preparations and medicines; scientific research consultancy in relation to assessments, estimates, and researches in science and technology rendered by engineers; providing information in the nature of evaluations and estimations in the field of medical research; industrial research and biological analysis in the field of health; providing of imaging and physiology platforms, namely, providing temporary use of online non-downloadable software for analysing medical imaging; research and development of pharmaceuticals and veterinary and hygiene preparations for others; product development and testing of pharmaceuticals in the validation of biological tests, cellular tests, genetic tests and immunological tests of others; gene therapy research and scientific research counselling, in relation to research services and therapy | ACTIVE | — |
| 044 | Medical services; medical screening; medical assistance; medical counselling; providing news and information in the field of medicine; performing diagnosis of diseases; medical advisory services relating to degenerative diseases; medical surgical diagnostic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; human hygiene and beauty care; health counselling; hospital services; nursing home services; pharmaceutical advice, namely, prescription management and reviews being medication counseling; medical imaging services; human tissue bank services; conducting of medical examinations; medical consultations; medical and health care services relating to DNA, genetics and genetic testing; telemedicine services; stem cell therapy services; preparation and dispensing of medications; providing of medical information in the pharmaceutical field; medical, alternative medicinal and pharmaceutical consultancy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FONDAZIONE TELETHON ETS
- Other trademarks owned by FONDAZIONE TELETHON ETS
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named STRIMVELIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 8, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 2, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 13, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 20, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 26, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 26, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 23, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 22, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 4, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 27, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |